[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2013/46136,2013,A1Locationinpatent:Page/Pagecolumn169;170
2413900-50-0
51412-23-8
868552-05-0
1106959-86-7
1185292-99-2
400877-10-3
937263-43-9 | Irbinitinib | AA00GTX3 | MFCD22380467
882257-11-6 | P-5091 | AA00GU2F | MFCD00123202
897657-95-3 | Msx-122 | AA00GU6X | MFCD18803971
875164-01-5 | 2-(8-Methyl-4-oxoquinazolin-3(4H)-yl)acetic acid | AA00GUAS | MFCD07838429
923695-17-4 | 4-METHOXY-2-(METHOXYMETHYL)-5-METHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID | AA00GUE8 | MFCD08271731
912669-58-0 | 5-Chloro-1,3,4-thiadiazole-2-methanol | AA00GUM9 | MFCD14155682
915107-39-0 | 6-Chloro-5-methoxynicotinic acid | AA00GUU7 | MFCD12828186
877319-43-2 | [2-(4-FLUORO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER | AA00GV85 | MFCD08692500
906353-04-6 | 2-Morpholin-4-yl-1,3-thiazole-4-carboxylic acid | AA00GVEB | MFCD09702410
93372-65-7 | 1-Amino-3-methoxypropan-2-ol | AA00GVJE | MFCD00462795